Mark A. Cook
Cancer Research
UK Institute for Cancer Studies
University of Birmingham
Birmingham
United Kingdom
Name/email consistency: high
- The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Cook, M.A., Milligan, D.W., Fegan, C.D., Darbyshire, P.J., Mahendra, P., Craddock, C.F., Moss, P.A., Briggs, D.C. Blood (2004)
- A multi-laboratory characterization of the KIR genotypes of 10th International Histocompatibility Workshop cell lines. Cook, M.A., Norman, P.J., Curran, M.D., Maxwell, L.D., Briggs, D.C., Middleton, D., Vaughan, R.W. Hum. Immunol. (2003)
- Used leucodepletion filters as a source of large quantities of DNA suitable for the study of genetic variations in human populations. Cook, M.A., Jobson, S.E., Atkinson, D.C., Lowe, D.P., Farmer, S.L., Alvi-Ali, W.J., Smith, N.A., Briggs, D.C. Transfus. Med (2003)
- The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. Cook, M.A., Moss, P.A., Briggs, D.C. Eur. J. Immunogenet. (2003)